Do you have cutting-edge technology to develop new therapeutic agents—leveraging AI to create small molecules or biologics faster, cheaper, and more effectively than your competition? Now, you’re at a crossroads: selecting the right target and indication to drive your next phase of development and secure additional funding. To stand out to investors, you need a solid data package that answers two key questions: This isn’t easy. Consider B-cell lymphoma alone: the list of clinically pursued surface targets exceeds 10 (as shown in this review. For triple-negative breast cancer (TNBC), according to this review, the number of relevant targets skyrockets to over 25. When you include small molecule targets and repurposing candidates across many oncologic indications, the potential target list expands into the hundreds. What’s fascinating is that many of these targets seem plausible, backed by multiple lines of evidence. But as a small company, you need to narrow this down to the top five. So, how do you even begin? That’s where we come in. As a professional services firm, we specialize in helping biotech companies like yours make smart, strategic decisions using our proven multi-omic methodology. Whether you’re looking for targets in common or rare indications, we tailor our approach to your unique technology and goals. Reach out today for a free 30-minute consultation to discuss your project, and request an example case study to see how we can help. Let us simplify your decision-making process and give you the insights needed to move forward with confidence!

Do you have cutting-edge technology that your customers rely on—such as advanced cell lines, animal models, or proprietary antibody generation platforms? Do you want to benchmark your technology against the competition? Or are you looking to offer additional services to your clients, enhancing your value proposition and standing out in a crowded marketplace? We can help! Our team leverages advanced technologies like Next-Generation Sequencing (NGS) and multiomic analysis, including spatial transcriptomics, to provide deep insights and comparisons. Here’s how we support CROs like yours: Whether you’re aiming to increase customer satisfaction, differentiate your offerings, or introduce new revenue-generating services, we have the expertise and the tools to help you thrive. Reach out today for a free consultation to explore how we can help your CRO harness the power of NGS, multiomics, and spatial technologies to enhance your market position and deliver exceptional value to your clients.